OBJECTIVE: To map the current evidence regarding the safety and efficacy of GLP-1 RMs in the management of dumping syndrome following MBS, recognising dumping syndrome as a broader clinical entity encompassing symptoms, quality of life, and glucose stabilisation. Here, GLP1R is linked to dumping syndrome.